Antibody-CD20-interferon-alpha fusion protein has superior in vivo activity against human B cell lymphomas compared to Rituximab, and enhanced complement-dependent cytotoxicity in...

por Yamada, Reiko, Steward, Kristopher, Ngarmchamnanrith, Gataree, Trinh, Ryan, Khare, Sanjay, Sachdev, Raj, Grewal, Iqbal, Morrison, Sherie, Timmerman, John
Publicado 2013